Cell Reprogramming & Therapeutics LLC is focused on the development and commercialization of cell-based technologies to target diseases of the central nervous system. The company’s programs aim to develop cellular models and therapeutics for neurological disorders such as Brain and Spinal cord injuries, Stroke, Parkinson's, Alzheimer's, Amyotrophic Lateral Sclerosis , Huntington's and brain malignancies.
Two decades ago, the pharmaceutical industry, long dominated by small-molecule drugs, was revolutionized by the advent of biologics. Today, biomedicine sits on the cusp of a new revolution: the use of microbial and human cells as versatile therapeutic engines. However, the advent of cellular medicines will require the development of a foundational cellular engineering science that provides a systematic framework for safely and predictably altering and regulating cellular behaviors. Recent advances in cell reprogramming technologies to generate patient-specific cells of a desired type have opened new horizons for cell-based therapies and regenerative medicine.
Copyright © 2020 Cell Reprogramming & Therapeutics LLC - All Rights Reserved.